Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

About the Cover

May 1, 2016; Volume 57,Issue 5

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 8A;

SNMMI Newsline

  • You have access
    NIH Targets Links Between Vascular Disease and AD
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 11N;
  • You have access
    Cancer Death Rates Continue to Decline
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 12N;
  • You have access
    Interactive Mapping of Medicare Disparities
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 12N;
  • You have access
    Siegel Recognized for Nuclear Contributions
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 13N;
  • You have access
    In Memoriam: Edwaldo E. Camargo, MD 1938–2016
    Homer Macapinlac and Steven M. Larson
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 14N;
  • You have access
    SNMMI Leadership Update: Focus on Quality: Update on the Development of Evidence-Based Appropriate Use Criteria
    Virginia Pappas
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 15N;
  • You have access
    Newsbriefs
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 16N-17N;
  • You have access
    From the Literature
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 18N-22N;

Invited Perspectives

  • You have access
    Molecular Imaging Approaches for Supplemental Screening in Women at Increased Breast Cancer Risk
    Amy M. Fowler
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 661-662; DOI: https://doi.org/10.2967/jnumed.115.171330
  • You have access
    Emerging Opportunities for c-MET Visualization in the Clinic
    Martin Pool, Gooitzen M. van Dam and Elisabeth G.E. de Vries
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 663-664; DOI: https://doi.org/10.2967/jnumed.115.169771

Clinical Investigations

  • You have access
    90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study
    Ryan Hickey, Robert J. Lewandowski, Totianna Prudhomme, Eduardo Ehrenwald, Brian Baigorri, Jeffrey Critchfield, Joseph Kallini, Ahmed Gabr, Boris Gorodetski, Jean-Francois Geschwind, Andrea Abbott, Ravi Shridhar, Sarah B. White, William S. Rilling, Brendan Boyer, Shannon Kauffman, Sharon Kwan, Siddarth A. Padia, Vanessa L. Gates, Mary Mulcahy, Sheetal Kircher, Halla Nimeiri, Al B. Benson and Riad Salem
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 665-671; DOI: https://doi.org/10.2967/jnumed.115.166082
  • You have access
    Comparing the Diagnostic Potential of 68Ga-Alfatide II and 18F-FDG in Differentiating Between Non–Small Cell Lung Cancer and Tuberculosis
    Fei Kang, Shengjun Wang, Feng Tian, Mingxuan Zhao, Mingru Zhang, Zhe Wang, Guoquan Li, Changli Liu, Weidong Yang, Xiaofei Li and Jing Wang
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 672-677; DOI: https://doi.org/10.2967/jnumed.115.167924
  • You have access
    Breast-Specific γ-Imaging for the Detection of Mammographically Occult Breast Cancer in Women at Increased Risk
    Rachel F. Brem, Rachel C. Ruda, Jialu L. Yang, Caitrín M. Coffey and Jocelyn A. Rapelyea
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 678-684; DOI: https://doi.org/10.2967/jnumed.115.168385
  • You have access
    Risk of Breast Cancer in Patients with Thyroid Cancer Receiving or Not Receiving 131I Treatment: A Nationwide Population-Based Cohort Study
    Chun-Yi Lin, Cheng-Li Lin, Wen-Sheng Huang and Chia-Hung Kao
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 685-690; DOI: https://doi.org/10.2967/jnumed.115.164830
  • You have access
    The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer
    Peter S.N. van Rossum, David V. Fried, Lifei Zhang, Wayne L. Hofstetter, Marco van Vulpen, Gert J. Meijer, Laurence E. Court and Steven H. Lin
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 691-700; DOI: https://doi.org/10.2967/jnumed.115.163766
  • You have access
    124I PET/CT to Predict the Outcome of Blind 131I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET)
    Jakob W. Kist, Bart de Keizer, Manfred van der Vlies, Adrienne H. Brouwers, Dyde A. Huysmans, Friso M. van der Zant, Rick Hermsen, Marcel P.M. Stokkel, Otto S. Hoekstra and Wouter V. Vogel; for the THYROPET Study Group
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 701-707; DOI: https://doi.org/10.2967/jnumed.115.168138
  • You have access
    Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors
    Stephen A. Deppen, Eric Liu, Jeffrey D. Blume, Jeffrey Clanton, Chanjuan Shi, Laurie B. Jones-Jackson, Vipul Lakhani, Richard P. Baum, Jordan Berlin, Gary T. Smith, Michael Graham, Martin P. Sandler, Dominique Delbeke and Ronald C. Walker
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 708-714; DOI: https://doi.org/10.2967/jnumed.115.163865
  • You have access
    Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study
    Yaping Luo, Qingqing Pan, Shaobo Yao, Miao Yu, Wenming Wu, Huadan Xue, Dale O. Kiesewetter, Zhaohui Zhu, Fang Li, Yupei Zhao and Xiaoyuan Chen
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 715-720; DOI: https://doi.org/10.2967/jnumed.115.167445
  • You have access
    Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer
    Daniela E. Oprea-Lager, Gem Kramer, Peter M. van de Ven, Alfons J.M. van den Eertwegh, Reindert J.A. van Moorselaar, Patrick Schober, Otto S. Hoekstra, Adriaan A. Lammertsma and Ronald Boellaard
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 721-727; DOI: https://doi.org/10.2967/jnumed.115.167692
  • You have access
    Prospective Study of 3′-Deoxy-3′-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma
    Heiko Schöder, Andrew D. Zelenetz, Paul Hamlin, Somali Gavane, Steven Horwitz, Matthew Matasar, Alison Moskowitz, Ariela Noy, Lia Palomba, Carol Portlock, David Straus, Ravinder Grewal, Jocelyn C. Migliacci, Steven M. Larson and Craig H. Moskowitz
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 728-734; DOI: https://doi.org/10.2967/jnumed.115.166769
  • You have access
    Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor
    Joo Hyun O, Brandon S. Luber, Jeffrey P. Leal, Hao Wang, Vanessa Bolejack, Scott M. Schuetze, Lawrence H. Schwartz, Lee J. Helman, Denise Reinke, Laurence H. Baker and Richard L. Wahl
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 735-740; DOI: https://doi.org/10.2967/jnumed.115.162412
  • You have access
    First Experience with Chemokine Receptor CXCR4–Targeted PET Imaging of Patients with Solid Cancers
    Tibor Vag, Carlos Gerngross, Peter Herhaus, Matthias Eiber, Kathrin Philipp-Abbrederis, Frank-Philipp Graner, Johannes Ettl, Ulrich Keller, Hans-Jürgen Wester and Markus Schwaiger
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 741-746; DOI: https://doi.org/10.2967/jnumed.115.161034
  • You have access
    Microfluidic Preparation of a 89Zr-Labeled Trastuzumab Single-Patient Dose
    Brian D. Wright, Joseph Whittenberg, Amit Desai, Christina DiFelice, Paul J.A. Kenis, Suzanne E. Lapi and David E. Reichert
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 747-752; DOI: https://doi.org/10.2967/jnumed.115.166140

Basic Science Investigations

  • You have access
    A Method to Improve the Semiquantification of 18F-FDG Uptake: Reliability of the Estimated Lean Body Mass Using the Conventional, Low-Dose CT from PET/CT
    Pierre Decazes, Denis Métivier, Alexandra Rouquette, Jean-Noël Talbot and Khaldoun Kerrou
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 753-758; DOI: https://doi.org/10.2967/jnumed.115.164913
  • You have access
    Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy
    Elif Hindié, Paolo Zanotti-Fregonara, Michele A. Quinto, Clément Morgat and Christophe Champion
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 759-764; DOI: https://doi.org/10.2967/jnumed.115.170423
  • You have access
    c-Met PET Imaging Detects Early-Stage Locoregional Recurrence of Basal-Like Breast Cancer
    Appitha Arulappu, Mark Battle, Michel Eisenblaetter, Graeme McRobbie, Imtiaz Khan, James Monypenny, Gregory Weitsman, Myria Galazi, Susan Hoppmann, Patrycja Gazinska, Wulan Wulaningsih, Grethe Tang Dalsgaard, Sven Macholl and Tony Ng
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 765-770; DOI: https://doi.org/10.2967/jnumed.115.164384
  • You have access
    Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis
    Sai Kiran Sharma, Kuntal K. Sevak, Sebastien Monette, Sean D. Carlin, James C. Knight, Frank R. Wuest, Evis Sala, Brian M. Zeglis and Jason S. Lewis
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 771-776; DOI: https://doi.org/10.2967/jnumed.115.167072
  • You have access
    Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain
    Nabeel B. Nabulsi, Joël Mercier, Daniel Holden, Stephane Carré, Soheila Najafzadeh, Marie-Christine Vandergeten, Shu-fei Lin, Anand Deo, Nathalie Price, Martyn Wood, Teresa Lara-Jaime, Florian Montel, Marc Laruelle, Richard E. Carson, Jonas Hannestad and Yiyun Huang
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 777-784; DOI: https://doi.org/10.2967/jnumed.115.168179
  • You have access
    Pharmacokinetic Analysis of 11C-PBR28 in the Rat Model of Herpes Encephalitis: Comparison with (R)-11C-PK11195
    Andrea Parente, Paula Kopschina Feltes, David Vállez García, Jurgen W.A. Sijbesma, Cristina M. Moriguchi Jeckel, Rudi A.J.O. Dierckx, Erik F.J. de Vries and Janine Doorduin
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 785-791; DOI: https://doi.org/10.2967/jnumed.115.165019
  • You have access
    Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models
    Matthias Brendel, Anna Jaworska, Federico Probst, Felix Overhoff, Viktoria Korzhova, Simon Lindner, Janette Carlsen, Peter Bartenstein, Ryuichi Harada, Yukitsuka Kudo, Christian Haass, Fred Van Leuven, Nobuyuki Okamura, Jochen Herms and Axel Rominger
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 792-798; DOI: https://doi.org/10.2967/jnumed.115.163493
  • You have access
    Noninvasive Imaging of Islet Transplants with 111In-Exendin-3 SPECT/CT
    Inge van der Kroon, Karolina Andralojc, Stefanie M.A. Willekens, Desirée Bos, Lieke Joosten, Otto C. Boerman, Maarten Brom and Martin Gotthardt
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 799-804; DOI: https://doi.org/10.2967/jnumed.115.166330
  • You have access
    Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin
    Filipe Elvas, Christel Vangestel, Koon Pak, Peter Vermeulen, Brian Gray, Sigrid Stroobants, Steven Staelens and Leonie Wyffels
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 805-811; DOI: https://doi.org/10.2967/jnumed.115.168344
  • You have access
    Biodistribution and PET Imaging of Labeled Bispecific T Cell–Engaging Antibody Targeting EpCAM
    Frank J. Warnders, Stijn J.H. Waaijer, Martin Pool, Marjolijn N. Lub–de Hooge, Matthias Friedrich, Anton G.T. Terwisscha van Scheltinga, Petra Deegen, Sabine K. Stienen, Peter C. Pieslor, H.Kam Cheung, Jos G.W. Kosterink and Elisabeth G.E. de Vries
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 812-817; DOI: https://doi.org/10.2967/jnumed.115.168153
  • You have access
    Effect of Attenuation Correction on Regional Quantification Between PET/MR and PET/CT: A Multicenter Study Using a 3-Dimensional Brain Phantom
    Jarmo Teuho, Jarkko Johansson, Jani Linden, Adam Espe Hansen, Søren Holm, Sune H. Keller, Gaspar Delso, Patrick Veit-Haibach, Keiichi Magota, Virva Saunavaara, Tuula Tolvanen, Mika Teräs and Hidehiro Iida
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 818-824; DOI: https://doi.org/10.2967/jnumed.115.166165

Erratum

  • You have access
    Erratum
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 804;
  • You have access
    Erratum
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 825;

Book Reviews

  • You have access
    The Pathophysiologic Basis of Nuclear Medicine
    Mei Tian
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 825; DOI: https://doi.org/10.2967/jnumed.116.173815
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 57 (5)
Journal of Nuclear Medicine
Vol. 57, Issue 5
May 1, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Molecular Imaging Approaches for Supplemental Screening in Women at Increased Breast Cancer Risk
  • Comparing the Diagnostic Potential of 68Ga-Alfatide II and 18F-FDG in Differentiating Between Non–Small Cell Lung Cancer and Tuberculosis
  • Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer
  • Prospective Study of 3′-Deoxy-3′-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma
Sign up for alerts

Jump to

  • This Month in JNM
  • SNMMI Newsline
  • Invited Perspectives
  • Clinical Investigations
  • Basic Science Investigations
  • Erratum
  • Book Reviews
  • Most Cited
  • Most Read
Loading
  • Initial Clinical Experience with 90Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
  • Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
  • Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
  • Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial
  • 68Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the 68Ga-FAPI PET Prospective Observational Trial
More...
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire